6Kurul S, Saip P, Aydin T. Totally implantable venous-access-ports : local problems and extravasation injury. Lancet OncoI, 2002, 3 ( 11 ) :684-692.
7Biffi R, Pozzi S, Agazzi A, et al. Use of totally implantable central venous access ports for high dose chemotherapy and peripheral blood stem cell transplantation: resuhs of a monocentre series of 376 patients. Ann Oncol,2004,15(2) :296-300.
8Vescia S, Baumgartnet AK, Jacobs VR, et al. Management of venous port systems in oncology : a review of current evidence. Ann Oneo1,2008,19 ( 1 ) :9-15.
9Kreis H, et al. Patientsttitudes to totally implantable venous access port systems for gynecological or breast malignancies. European Journal of Surgical Ontology(EJSO) ,2007,33( 1 ) :39-43.
10Haire WD, Atkinson JB, Stephens LC, et al. Urokinase versus recombinant tisse plasminogen avtiator in thrombosed ventral venouscatheters: a double-blinded, randomized trial . Thromb Haemost, 1994,72 (4) :543-547.
